Skip to content
Home
About
Team
Our Board
Management Team
Clinical Ambassadors
Corporate Governance
Our Name & Brandmark
Care Delivery
Pax Centre
Emerald Clinics
Maritime Health Clinic
Drug and Therapy Development
Psychedelic-Assisted Therapy
Ultra-Pure CBD Medicines
MDMA-inspired Medicines
Research & Data Programs
Investor Hub
Shareholder Communications
News
General News
Blogs
Publications
Investor Updates
In the Media
Contact
Menu
Home
About
Team
Our Board
Management Team
Clinical Ambassadors
Corporate Governance
Our Name & Brandmark
Care Delivery
Pax Centre
Emerald Clinics
Maritime Health Clinic
Drug and Therapy Development
Psychedelic-Assisted Therapy
Ultra-Pure CBD Medicines
MDMA-inspired Medicines
Research & Data Programs
Investor Hub
Shareholder Communications
News
General News
Blogs
Publications
Investor Updates
In the Media
Contact
Blogs
March 2, 2023
Blog: A Passion for Building Companies That Aim to Do Good
November 9, 2022
Why is Ultra-Pure CBD Key to Sustainable Cannabis-based Treatments?
July 12, 2022
Recent EFSA Decision Highlights Real World Data’s Importance
July 7, 2022
How Can Remote Monitoring Improve Our Healthcare System?
June 8, 2022
Promising EMD-RX5 Phase One Clinical Trial results unpacked
May 12, 2022
Blog: Bioavailability and its importance to drug development
March 29, 2022
Blog: The Importance of an Over-The-Counter Treatment for Psychological Distress
Search
Search
Search
Blogs
General News
In the Media
Information
Investor Updates
Publications
Uncategorised
